KIRD2 Subgroup, Human (Lirilumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Search, find, compare suppliers for anti-KIRD2 Subgroup, Human (Lirilumab biosimilar) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | KIRD2 Subgroup, Human (Lirilumab biosimilar) |
| Clone | Lirilumab |
| Host Species | Recombinant |
| Reactive Species | human |
| Isotype | Human IgG1 |
| Format | purified |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Applications | n/a |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Anti-Human KIRD2 Subgroup Recombinant Antibody. Lirilumab (INN) is a human monoclonal antibody designed for the treatment of cancer. It binds to KIR2DL1/2L3. This drug was developed by Innate Pharma and is licensed to Bristol-Myers Squibb. |
| Immunogen | n/a |
| Other Names | Anti-KIRD2 Subgroup Recombinant Antibody, Research Grade Lirilumab, Anti-Human KIRD2 Subgroup Recombinant Antibody, BMS-986015, IPH2102, Antibody Drug Analogues, Monoclonal Antibody, YR1284, Research Grade Biosimilars, Biosimilar Antibody |
| Gene, Accession # | CAS: 1000676-41-4 |
| Catalog # | YR1284 |
| Price | please inquire |
| Order / More Info | KIRD2 Subgroup, Human (Lirilumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
| Product Specific References | n/a |
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806
info@kmdbioscience.com
Sales: sales@kmdbiosci.com
https://www.kmdbioscience.com
Profile of KMD BIOSCIENCE CO. LTD.